Your browser doesn't support javascript.
loading
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
Shustov, Andrei; Cabrera, Maria Elena; Civallero, Monica; Bellei, Monica; Ko, Young Hyeh; Manni, Martina; Skrypets, Tetiana; Horwitz, Steven M; De Souza, Carmino Antonio; Radford, John A; Bobillo, Sabela; Prates, Maria Virginia; Ferreri, Andrés J M; Chiattone, Carlos; Spina, Michele; Vose, Julie M; Chiappella, Annalisa; Laszlo, Daniele; Marino, Dario; Stelitano, Caterina; Federico, Massimo.
Afiliação
  • Shustov A; Division of Hematology, University of Washington, Seattle, WA.
  • Cabrera ME; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Civallero M; Seccion Hematologia, Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • Bellei M; CHIMOMO Department and.
  • Ko YH; Fondazione Italiana Linformi (FIL) onlus, University of Modena and Reggio Emilia, Modena, Italy.
  • Manni M; Department of Pathology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Skrypets T; CHIMOMO Department and.
  • Horwitz SM; CHIMOMO Department and.
  • De Souza CA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Radford JA; Centro de Hematologia e Hemoterapia, Universidale Estadual de Campinas, Campinas, Brazil.
  • Bobillo S; University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Prates MV; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Ferreri AJM; Gatla, Laboratorio Varifarma Sa, Buenos Aires, Argentina.
  • Chiattone C; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Spina M; Departamento de Clinica Medica, FCM da Santa Casa de Sao Paulo and Centro de Linfomas Nucleo de Oncologia Hospital Samaritano, São Paulo, Brazil.
  • Vose JM; Medical Oncology A, Aviano National Cancer Institute, Aviano, Italy.
  • Chiappella A; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE.
  • Laszlo D; Fondazione Italiana Linfomi, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Marino D; Division of Haemato-Oncology, Istituto Europeodi Oncologia, Milan, Italy.
  • Stelitano C; Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS Padua, Padua, Italy; and.
  • Federico M; Department of Haematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.
Blood Adv ; 5(3): 640-648, 2021 02 09.
Article em En | MEDLINE | ID: mdl-33560375
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Anaplásico de Células Grandes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Anaplásico de Células Grandes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article